Search Results
Found 1 results
510(k) Data Aggregation
(120 days)
The ARTiC-L™ 3D Ti Spinal System with TiONIC™ Technology is indicated for use as an intervertebral body fusion device in skeletally mature patients with degenerative disc disease (DDD - defined by discogenic back pain with degeneration of the disc confirmed by patient history and radiographic studies) at one or two contiguous levels of the lumbar spine (L2-S1). Additionally, ARTiC-L™ 3D Ti Spinal System can be used in patients diagnosed with spinal deformities as an adjunct to fusion. These patients should be skeletally mature and have undergone 6 months of nonoperative treatment prior to surgery. These implants are used to facilitate fusion in the lumbar spine using autogenous bone and/or allogenic bone graft comprised of cancellous bone graft. When used as an interbody fusion device, these implants are intended for use with supplemental internal fixation systems.
The ARTiC-XL™ 3D Ti Spinal System with TiONIC™ Technology is indicated for use as an intervertebral body fusion device in skeletally mature patients with degenerative disc disease (DDD - defined by discogenic back pain with degeneration of the disc confirmed by patient history and radiographic studies) at one or two contiguous levels of the lumbar spine (L2-S1). Additionally, ARTIC-XL™ 3D Ti Spinal System can be used in patients diagnosed with spinal deformities as an adjunct to fusion. These patients should be skeletally mature and have undergone 6 months of nonoperative treatment prior to surgery. These implants are used to facilitate fusion in the lumbar spine using autogenous bone and/or allogenic bone graft comprised of cancellous bone graft. When used as an interbody fusion device, these implants are intended for use with supplemental internal fixation systems.
The ARTIC-L™ and ARTIC-XL™ 3D Ti Spinal Systems with TiONIC™ Technology consist of additively manufactured (AM) titanium spacers of various widths, lengths, heights and lordotic angles and reusable instruments used for implantation and extraction of the subject implant. The instruments may be transported to the customer in cases, trays and lids which can also be used for sterilization. These implants are intended to be surgically placed between two lumbar or lumbosacral vertebral bodies to give support and correction during lumbar intervertebral body fusion surgical procedures.
This document describes the regulatory submission for the Medtronic ARTiC-L™ 3D Ti Spinal System and ARTiC-XL™ 3D Ti Spinal System with TiONIC™ Technology. The submission is a 510(k) premarket notification, which demonstrates substantial equivalence to legally marketed predicate devices.
1. Acceptance Criteria and Reported Device Performance
The acceptance criteria for this device are based on demonstrating substantial equivalence to predicate devices, primarily through mechanical performance, biocompatibility, and MRI safety. The document doesn't present a table with explicit numerical acceptance criteria values alongside reported device performance. Instead, it states that the tests were performed "in accordance with" relevant ASTM standards and guidance documents, implying that the acceptance criteria are adherence to these established standards and comparable performance to predicates.
The reported device performance is presented as:
| Test Category | Acceptance Criteria (Implied) | Reported Device Performance |
|---|---|---|
| Biocompatibility | Adherence to "Use of International Standard ISO-10993, Biological Evaluation of Medical Devices Part 1: Evaluation and Testing within a Risk Management Process" (FDA Guidance, June 16, 2016). | - Evaluated for permanent, >30-day body contact for implants. - Materials: Titanium-6 Aluminum-4 Vanadium ELI. - Tests performed: Chemical Characterization, Toxicological Risk Assessment, Cytotoxicity, Acute Systemic Toxicity, Material Mediated Pyrogenicity. - Results: "Based on the results, no additional testing was required." (Implies successful completion and adherence to safety profiles). - Bacterial Endotoxin (LAL) test: Successfully met 20 EU/device pyrogen limit specification (as per ANSI/AAMI ST72 and USP <161>). - Instruments (non-sterile, external communicating for <24 hr contact): Materials are Stainless Steel (ASTM F899, A564, A693) and Titanium Alloy ELI (ASTM F136). "No new biocompatibility testing is required" due to use of same materials as predicate. |
| Mechanical Testing | Adherence to "Guidance for Industry and FDA Staff – Spinal System 510(k)'s" and specific ASTM standards (ASTM F2077-14, F2267-04, F-04.25.02.02 Draft, F1877-16). | - Bench testing completed to demonstrate substantial equivalence to predicates. - Performed tests: Static Compression, Static Compression-Shear, Compression Fatigue, Compression-Shear Fatigue (all per ASTM F2077-14). - Load-Induced Subsidence (ASTM F2267-04). - Static Push-out (ASTM Draft F-04.25.02.02). - Particle Characterization (ASTM F1877-16). - Results: "the results of these tests demonstrated the substantial equivalence of the subject devices to the predicates." |
| MRI Safety | Adherence to specific ASTM standards (ASTM F2052, F2213, F2119, F2182). | - Performed tests: Measurement of magnetically induced displacement force (ASTM F2052), magnetically induced torque (ASTM F2213), MR image artifacts (ASTM F2119), radio frequency induced heating (ASTM F2182). - Results: Not explicitly stated as "passed" for each, but the overall conclusion states the device is "as safe and effective as the following predicates" which implicitly includes MRI safety. |
| Design Validation | User needs met and intended function demonstrated. | - Performed using saw bone models and/or cadaver lab (Tru-Trainer). - Results: "Design Validation demonstrated the subject implants and instruments function as intended and user needs were met." |
2. Sample Size and Data Provenance
The document does not specify exact sample sizes for the mechanical tests, biocompatibility tests, or design validation beyond referring to the standards by which they were conducted. For mechanical testing, the standards (e.g., ASTM F2077-14) would typically define minimum sample sizes.
The data provenance is not explicitly stated in terms of country of origin. The submission is made by Medtronic Sofamor Danek, USA Inc., and the FDA is a US regulatory body, suggesting the studies were likely conducted in the US or in adherence to US regulatory expectations. The studies described are pre-market design validation and verification activities, inherently prospective in their nature as they involve testing the medical device itself. They are not clinical studies on patient populations.
3. Number of Experts and Qualifications for Ground Truth
This submission does not involve AI or algorithms that require human expert assessment for "ground truth" in the typical sense of image interpretation or diagnostic accuracy. The "ground truth" here is established through bench testing against engineering standards and material properties, and validation through physical models (saw bones/cadavers). Therefore, the concept of "number of experts," their qualifications, or adjudication methods for establishing "ground truth" (as it relates to diagnostic accuracy) is not applicable to this type of device submission. Expertise would lie within the engineering and scientific teams conducting the tests and interpreting the physical and chemical properties.
4. Adjudication Method
Not applicable, as described above.
5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study
Not applicable. This is a spinal implant device, not an AI-assisted diagnostic tool. Therefore, an MRMC study comparing human reader performance with and without AI assistance is not relevant to this submission.
6. Standalone (Algorithm only) Performance
Not applicable, as there is no standalone algorithm in this context. The device is a physical implant.
7. Type of Ground Truth Used
The ground truth used for this device is based on:
- Engineering standards and material specifications: For biocompatibility, mechanical strength, and MRI safety, adherence to established ASTM and ISO standards defines acceptable performance.
- Physical models/Cadaveric studies: For design validation, including proper fit, function, and surgical feasibility, using saw bones and cadaver models serves as functional ground truth in a pre-clinical setting.
8. Sample Size for Training Set
Not applicable. This is a physical medical device, not a machine learning model, so there is no "training set."
9. How the Ground Truth for the Training Set was Established
Not applicable, as there is no training set.
Ask a specific question about this device
Page 1 of 1